Estrogens, Conjugated (USP)
Estrogens, Conjugated (USP) is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
1 source entries across 1 studies. This list may not include all unresolved or historical entries.
- Estrogens, Conjugated (USP)Registry intervention
Linked study entry; product equivalence not established
View study and source
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2/3Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
0
trials recruiting
3
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy
Estrogen, HDL, and Coronary Heart Disease in Women
Vascular Effect of Estrogens Versus Placebo Evaluated by Flow-mediated Dilatation of Brachial Artery
Clinical Trials (3)
Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy
Estrogen, HDL, and Coronary Heart Disease in Women
Vascular Effect of Estrogens Versus Placebo Evaluated by Flow-mediated Dilatation of Brachial Artery
All 3 trials loaded
Drug Details
- Intervention Type
- Drug
- Total Trials
- 3